and Sinovac
Rich countries corner nearly 51% supply of five major COVID-19 vaccine candidates: Oxfam
According to a recent study by Oxfam International, wealthy nations, which account for nearly 13% of the global population, have cornered a lion’s share of supply deals for vaccine candidates in phase-3 of the clinical trials
- Trump’s mass deportation operation escalates with workplace raids
- Jordan bans Muslim Brotherhood, confiscates its assets after alleged security plot
- Medics on hunger strike against Gaza genocide reach European Parliament
- Samidoun Europe coordinator targeted again by Belgian police
- Syria’s interim government arrests senior Palestinian resistance leaders
